title: Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease.
abstract: Existing murine models for cutaneous herpes simplex virus type 1 (HSV-1) infection have limited relevance to recurrent disease in humans, since the infection is usually primary rather than reactivated and infection occurs in the absence of an established immune response. To obtain a reproducible model to study the effects of topical antiviral therapy on recurrent disease we have adapted a mouse model which employs zosteriform spread of HSV-1 in the presence of adoptive transfer of immunity (ATI) which mimics human recrudescent lesions. Mice were infected with HSV-1 by scarification at the lateroventral line of the neck; 2 days later, the mice received adoptive transfer of immune cells from the cervical lymph nodes of syngeneic mice that had been infected in the ear pinna with the same strain of virus 7 days earlier. ATI resulted in a heightened inflammatory response in the target tissues for virus replication. Virus was cleared more quickly from the infected tissues in comparison with mice similarly inoculated without ATI, however, the intensity and duration of the inflammation was greater. The model was then used to test the effect of a topical formulation of foscarnet. The results presented demonstrate that the ATI model can provide useful data concerning the efficacy of topical antiviral chemotherapy in man.
authors.affiliation: Centre for Veterinary Science, University of Cambridge, UK.
authors.forename: A R
authors.initials: AR
authors.lastname: Awan
authors.forename: J
authors.initials: J
authors.lastname: Harmenberg
authors.forename: A
authors.initials: A
authors.lastname: Kristofferson
authors.forename: H J
authors.initials: HJ
authors.lastname: Field
mesh_terms: D000287:Administration, Topical; D019264:Adoptive Transfer; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002460:Cell Line; D006224:Cricetinae; D004195:Disease Models, Animal; D004423:Ear; D005260:Female; D017245:Foscarnet / Q000008:administration & dosage / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D012008:Recurrence
chemical_list: D000998:Antiviral Agents; D017245:Foscarnet